Skip to main content
Earnings Labs
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ·Healthcare·Biotechnology

$2.78

+0.00%

Mkt Cap $214.58M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$5.00

Range $5.00$5.00

Implied Upside

+79.9%

Consensus $5.00 vs current $2.78